Target intelligence / Profile preview

Cholecystokinin (CCK)

Target
CCK
Molecular classification
Hormone, Peptide hormone, Neuropeptide
01

Overview

Cholecystokinin (CCK) is a peptide hormone produced by I-cells in the mucosal lining of the upper small intestine (duodenum and jejunum) and also by certain neurons in the brain. Its secretion is stimulated primarily by the presence of fats and proteins in the intestinal lumen. Upon release, CCK acts on its receptors (mainly cholecystokinin receptor 1, CCK1R) on the pancreas and gallbladder to stimulate the release of digestive enzymes and bile. It also slows gastric emptying, increases intestinal motility, and triggers signals of satiety to the brain. CCK also functions as a neuropeptide, influencing behavior and central nervous system signaling. The release mechanism is tightly regulated via nutrient sensing and neurohumoral pathways.

Other names
Pancreozymin (historical)CCK
02

Mechanism of action

Drugs that mimic CCK stimulate gallbladder contraction and pancreatic secretion. CCK receptor antagonists block these processes and reduce GI motility or secretion.

03

Biological functions

Stimulates pancreatic enzyme secretionTriggers gallbladder contraction (bile release)Inhibits gastric emptyingRegulates satiety and appetiteStimulates intestinal motilityActs as a neuropeptide in the brain
04

Disease associations

Malabsorption (in deficiency)Potential roles in anxiety disorders and schizophrenia (via imbalance in central CCK pathways)Potential effects in eating disorders and gastrointestinal disordersNeuroendocrine tumors (proCCK expression)
05

Safety considerations

The use of CCK (or its analogs) can cause abdominal pain, nausea, risk of pancreatitis, and allergic reactions in diagnostic contexts.
06

Interacting drugs

Synthetic CCK analogs (for diagnostic imaging and gallbladder function test)

1 more in the full profile.

07

Biomarkers

Circulating CCK (or processed forms of proCCK) measured in certain diagnostic tests

Beyond the preview

Go deeper on Cholecystokinin (CCK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholecystokinin (CCK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call